Can a common diabetes drug actually slow aging? Doctors review metformin ...

A common diabetes drug may help slow age-related vision loss, giving researchers a promising new clue for protecting eyesight ...

Weight loss and diabetes drugs such as Mounjaro, Ozempic, and Wegovy are linked to an increased risk of hair loss, ...

Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy ...

The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.

No difference in insulin discontinuation rates seen among three glucose-lowering classes ...

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers ...

Discover how a common diabetes medication, metformin, could significantly reduce the risk of age-related macular degeneration ...

Boehringer Ingelheim’s top-selling drug lifted sales in the first half, as the German drugmaker gears up to file for U.S.

Novo Nordisk sued Eli Lilly, alleging misleading ads unfairly compare doses of Zepbound and Mounjaro with Wegovy and Ozempic.

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every ...

China will add a second GLP-1 drug, used to treat diabetes, to a list of essential drugs all public hospitals are required ...